September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
August 26, 2024 NVDA Earnings Report Insights
August 22, 2024 Massive U.S. Job Growth Revision Shakes Economy And Markets
Amazon: Loading Up On This No-Brainer Buy Now
Apple: Not Surprising That Berkshire Sold Half
Wall Street Brunch: ‘It’s Glowtime’ For Apple
Nvidia: The Blackwell Delay And Its Consequences
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Oramed Pharmaceuticals (ORMP) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: September 9, 2024 (21:16)
Sector: HealthcareThe share price of Oramed Pharmaceuticals Inc. (ORMP) now
Are you interested in Oramed Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Oramed Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Oramed Pharmaceuticals share be worth in 2024 - 2028?
When should I take profit in Oramed Pharmaceuticals stock? When should I record a loss on Oramed Pharmaceuticals stock? What are analysts' forecasts for Oramed Pharmaceuticals stock? What is the future of Oramed Pharmaceuticals stock? We forecast Oramed Pharmaceuticals stock performance using neural networks based on historical data on Oramed Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Oramed Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Oramed Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Oramed Pharmaceuticals stock
The chart below shows the historical price of Oramed Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Oramed Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Oramed Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Sep 11 | 2.48 | 2.44 | 2.53 | 3.70 |
| Sep 12 | 2.50 | 2.47 | 2.55 | 3.19 |
| Sep 13 | 2.53 | 2.47 | 2.56 | 3.45 |
| Sep 14 | 2.47 | 2.39 | 2.50 | 4.45 |
| Sep 15 | 2.46 | 2.44 | 2.52 | 3.43 |
| Sep 16 | 2.56 | 2.53 | 2.62 | 3.84 |
| Sep 17 | 2.55 | 2.49 | 2.59 | 4.00 |
| Sep 18 | 2.55 | 2.48 | 2.60 | 4.85 |
| Sep 19 | 2.57 | 2.51 | 2.65 | 5.79 |
| Sep 20 | 2.62 | 2.59 | 2.68 | 3.56 |
| Sep 21 | 2.54 | 2.47 | 2.57 | 4.15 |
| Sep 22 | 2.54 | 2.51 | 2.60 | 3.73 |
| Sep 23 | 2.55 | 2.53 | 2.61 | 3.36 |
| Sep 24 | 2.60 | 2.56 | 2.67 | 4.52 |
| Sep 25 | 2.64 | 2.55 | 2.67 | 4.59 |
| Sep 26 | 2.65 | 2.59 | 2.72 | 5.07 |
| Sep 27 | 2.64 | 2.61 | 2.69 | 2.91 |
| Sep 28 | 2.67 | 2.64 | 2.73 | 3.49 |
| Sep 29 | 2.72 | 2.67 | 2.79 | 4.65 |
| Sep 30 | 2.77 | 2.70 | 2.80 | 3.81 |
| Oct 01 | 2.80 | 2.73 | 2.85 | 4.21 |
| Oct 02 | 2.77 | 2.72 | 2.83 | 4.19 |
| Oct 03 | 2.84 | 2.78 | 2.90 | 4.13 |
| Oct 04 | 2.85 | 2.80 | 2.88 | 2.77 |
| Oct 05 | 2.83 | 2.78 | 2.85 | 2.64 |
| Oct 06 | 2.91 | 2.84 | 2.95 | 4.02 |
| Oct 07 | 2.89 | 2.83 | 2.97 | 5.19 |
| Oct 08 | 2.82 | 2.77 | 2.89 | 4.28 |
| Oct 09 | 2.84 | 2.77 | 2.88 | 3.77 |
| Oct 10 | 2.87 | 2.79 | 2.93 | 4.81 |
Oramed Pharmaceuticals Daily Price Targets
Oramed Pharmaceuticals Stock Forecast 09-11-2024.
Forecast target price for 09-11-2024: $2.48.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.570%.
Pessimistic target level: 2.44
Optimistic target level: 2.53
Oramed Pharmaceuticals Stock Forecast 09-12-2024.
Forecast target price for 09-12-2024: $2.50.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.092%.
Pessimistic target level: 2.47
Optimistic target level: 2.55
Oramed Pharmaceuticals Stock Forecast 09-13-2024.
Forecast target price for 09-13-2024: $2.53.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.332%.
Pessimistic target level: 2.47
Optimistic target level: 2.56
Oramed Pharmaceuticals Stock Forecast 09-14-2024.
Forecast target price for 09-14-2024: $2.47.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 4.264%.
Pessimistic target level: 2.39
Optimistic target level: 2.50
Oramed Pharmaceuticals Stock Forecast 09-15-2024.
Forecast target price for 09-15-2024: $2.46.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.315%.
Pessimistic target level: 2.44
Optimistic target level: 2.52
Oramed Pharmaceuticals Stock Forecast 09-16-2024.
Forecast target price for 09-16-2024: $2.56.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.702%.
Pessimistic target level: 2.53
Optimistic target level: 2.62
ORMP (ORMP) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 2.60 | 2.33 | 2.69 | 13.36 |
| Nov. | 2.81 | 2.48 | 3.03 | 18.23 |
| Dec. | 2.62 | 2.40 | 2.80 | 14.33 |
Oramed Pharmaceuticals forecast for this year
Oramed Pharmaceuticals Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $2.60028. Pessimistic: $2.33. Optimistic: $2.69
Oramed Pharmaceuticals Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $2.8148. Pessimistic: $2.48. Optimistic: $3.03
Oramed Pharmaceuticals Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $2.62058. Pessimistic: $2.40. Optimistic: $2.80
Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.67 | 2.55 | 2.81 | 9.41 |
| Feb | 2.76 | 2.47 | 2.92 | 15.33 |
| Mar | 2.79 | 2.55 | 2.88 | 11.33 |
| Apr | 2.86 | 2.74 | 3.16 | 13.30 |
| May | 2.72 | 2.56 | 2.93 | 12.70 |
| Jun | 2.76 | 2.66 | 3.00 | 11.32 |
| Jul | 2.62 | 2.52 | 2.72 | 7.35 |
| Aug | 2.38 | 2.22 | 2.57 | 13.38 |
| Sep | 2.42 | 2.21 | 2.63 | 15.75 |
| Oct | 2.68 | 2.56 | 2.80 | 8.63 |
| Nov | 2.85 | 2.64 | 3.01 | 12.10 |
| Dec | 2.73 | 2.47 | 2.84 | 12.97 |
Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.82 | 2.58 | 2.90 | 11.20 |
| Feb | 2.98 | 2.63 | 3.32 | 20.52 |
| Mar | 2.96 | 2.66 | 3.26 | 18.51 |
| Apr | 3.24 | 2.91 | 3.45 | 15.64 |
| May | 2.90 | 2.63 | 3.13 | 15.86 |
| Jun | 3.11 | 2.97 | 3.47 | 14.50 |
| Jul | 2.97 | 2.75 | 3.32 | 17.19 |
| Aug | 2.57 | 2.40 | 2.81 | 14.68 |
| Sep | 2.87 | 2.55 | 3.20 | 20.30 |
| Oct | 2.75 | 2.43 | 3.07 | 20.84 |
| Nov | 2.93 | 2.59 | 3.16 | 18.32 |
| Dec | 3.12 | 2.77 | 3.40 | 18.58 |
Oramed Pharmaceuticals information and performance
HI-TECH PARK 2/4 GIVAT-RAM, PO BOX 39098, JERUSALEM, IL
Market capitalization of the Oramed Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ORMP shares in the company outstanding by the market price of one share.
EBITDA of Oramed Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
